EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease

Shilpa Sharma

Intestinal Research · 30.07.2025 · 23 (3) · 254-289

DOI: 10.5217/ir.2024.00185 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Intestinal Research, erschienen am 30.07.2025. Verfasst von Shilpa Sharma. Beteiligte Einrichtung: Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science, The University of Melbourne, Melbourne, Australia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 355 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions affecting the gastrointestinal tract that can lead to multiple systemic complications. Among these, osteosarcopenia has emerged as a significant concern, characterized by the concurrent deterioration of bone density and muscle mass, strength, and function. This dual deterioration significantly elevates the risk of falls and fractures, thereby exacerbating morbidity and diminishing quality of life. The pathogenesis of IBD-associated osteosarcopenia is multifactorial, with chronic intestinal inflammation serving as a central driver. Pro-inflammatory cytokines simultaneously disrupt bone homeostasis and muscle metabolism, creating a catabolic environment that impacts both tissues. Nutritional deficiencies, common in IBD due to malabsorption and decreased dietary intake, further compromise both bone mineralization and muscle protein synthesis. Management requires a comprehensive approach combining nutritional optimization, structured physical therapy, and lifestyle modifications. Pharmacological interventions integrate diseasespecific treatments with targeted therapies including vitamin D supplementation, hormonal treatments, and bisphosphonates when indicated. This review synthesizes current evidence regarding the prevalence, pathogenesis, and clinical impact of osteosarcopenia in IBD, highlighting areas requiring further investigation.

Schlagwörter

Stichwörter der Autor:innen

Bone lossInflammatory bowel diseaseMuscle lossOsteoporosisSarcopenia

Autor:innen und Institutionen

  • Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science, The University of Melbourne, Melbourne, Australia.

Zitieren

APA

Sharma, S. (2025). Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease. Intestinal Research, 23(3), 254-289. https://doi.org/10.5217/ir.2024.00185

Vancouver

Sharma S. Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease. Intestinal Research. 2025;23(3):254-289. doi:10.5217/ir.2024.00185

BibTeX
@article{Sharma2025,
  author = {Sharma, Shilpa},
  title = {Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease},
  journal = {Intestinal Research},
  year = {2025},
  volume = {23},
  number = {3},
  pages = {254--289},
  doi = {10.5217/ir.2024.00185}
}
Kostenlos starten →